Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

26.65 +0.35 (+1.33%)
Official Closing Price Updated: 4:10 PM EST, Feb 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
99 100 Next >
AbbVie Stock: A Perfect Dip for Investors to Buy
ABBV stock is down over 3% to start the second half of the year; the stock may be overvalued in the short term but still offers value for long-term investors 
Via MarketBeat
Topics ETFs
3 Undervalued Stocks Poised for a Jaw-Dropping Breakout
These three undervalued stocks have immense potential for a jaw-dropping breakout, offering triple-digit upside in the coming years. 
Via InvestorPlace
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
GSK and CureVac restructured their collaboration into a new licensing agreement, prioritizing mRNA vaccine development. GSK gains full control of vaccine candidates for influenza and COVID-19, while... 
Via Benzinga
Exposures COVID-19
Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
Clinical-state biopharmaceutical company Altimmune Inc. (NASDAQ: ALT) focuses on developing peptide-based therapeutics for obesity and chronic liver diseases 
Via MarketBeat
Exposures Product Safety
A Glimpse Into The Expert Outlook On Pfizer Through 9 Analysts
Via Benzinga
High Dividend 50: Pfizer Inc.
Pfizer currently pays a quarterly dividend of $0.42, for an annualized rate of $1.68 per share. This equates to a current dividend yield of 6% for Pfizer stock. 
Via Talk Markets
This Is What Whales Are Betting On Pfizer
Via Benzinga
London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents
Pfizer and Moderna continue their legal battle over COVID-19 vaccine patents following a mixed ruling by London's High Court, with potential appeals on the horizon and significant financial stakes... 
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout. 
Via MarketBeat
Topics ETFs
Exposures COVID-19
Heartburn Drug Zantac Litigation: GSK And Other Pharma Giants Face Trial Over Cancer Claims
A Delaware judge dismissed GSK and other drugmakers' appeal, allowing over 70,000 lawsuits alleging Zantac causes cancer to proceed, with the companies needing Delaware Supreme Court approval to... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
Pharmaceutical giant Pfizer Inc. (NYSE: PFE) has been trying to enter the weight-loss treatment trend dominated by GLP-1 drug makers like Ozempic and Wegovy 
Via MarketBeat
Is Pfizer Stock a Buy?
The stocks offers a hefty 6% dividend yield and is trading near decade lows. 
Via The Motley Fool
A Closer Look at Pfizer's Options Market Dynamics
Via Benzinga
1 Underwhelming Stat That May Have You Thinking Twice About Buying Pfizer's Stock
Pfizer's valuation looks attractive, but that doesn't mean the stock is a lock to outperform the broader market. 
Via The Motley Fool
3 Under-the-Radar Biotech Stocks With Blockbuster Potential
Are you looking to boost your portfolio with the best under-the-radar biotech stocks? Here are the top three. 
Via InvestorPlace
Time to Pounce: 2 Ultra-High-Yield Dividend Stocks That Are Begging to Be Bought for the Second Half of 2024 (and Beyond)
Two high-octane income stocks, which are premier companies sporting 6% yields within their respective industries, are historically cheap and ripe for the picking. 
Via The Motley Fool
Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.
There are more marketplace opportunities than just AI which is why these stocks that are outperforming Nvidia have done so well. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Amazon Web Services Focuses On The Future, Anticipating AI Challenges Years In Advance To Deliver 'True Value' For Customers
Amazon is taking an all-encompassing approach to enterprise AI in an effort to better deliver the tools that customers need when they need them. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Dividend Stocks Yielding Over 3% With Multi-Decade Payout Growth Streaks
Explore three high-yield dividend stocks that not only offer yields of 3% or more but also boast multiple decades of payout growth. 
Via InvestorPlace
2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
These reliable dividend payers are no-brainer buys right now. 
Via The Motley Fool
Cyrus Taraporevala Elected to Pfizer’s Board of Directors
From Pfizer Inc.
Via Business Wire
2 Ultra-High-Yield Dividend Stocks Billionaires Are Buying Left and Right: Could They Be Smart Buys for You in July?
With an average dividend yield of about 9.8% at recent prices, even a small investment in these stocks could significantly boost your passive income stream. 
Via The Motley Fool
4 Cheap Stocks to Buy in July
All four of these stocks are trading at very intriguing valuations. 
Via The Motley Fool
Shhh! 7 Stocks Quietly Lining Up for a Massive Surge in July.
Uncover the next big investment opportunities with these top stocks to buy, from AI advancements to robust financial performances. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Sectors That Could Get Slammed by Attempts to Reduce U.S. Debt
With Washington likely having to take steps to cut the U.S. deficit within the next few years, here are three sectors at risk. 
Via InvestorPlace
The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains
Consider buying shares in these pharma companies, each of which is a leader in the weight loss drug sector. 
Via InvestorPlace
2 Healthcare Stocks That Are Screaming Buys in June
These top healthcare stocks are no-brainer buys in 2024 and beyond. 
Via The Motley Fool
You’ve Been Warned! 3 Pharma Stocks to Buy Now or Regret Forever.
Pharmaceutical stocks can be considered risky, but when their trials get approved by FDA, the stock can go to the moon. 
Via InvestorPlace
Exposures Product Safety
3 Dividend Stocks to Buy If You Want Cash for Life
Cheap dividend stocks for cash flow are worth pursuing for investors seeking to rotate away from the red-hot AI-driven tech scene. 
Via InvestorPlace
Dow Jones Powerhouse Merck Dives On Surprise FDA Rejection
The FDA rejected Merck's Daiichi Sankyo-partnered antibody drug conjugate. 
Via Investor's Business Daily
Topics Stocks
Exposures Product Safety US Equities
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.